$265.97
0.78% yesterday
NYSE, Oct 07, 10:00 pm CET

West Pharmaceutical Services, Inc. Stock price

$265.97
+12.82 5.06% 1M
+64.50 32.01% 6M
-61.59 18.80% YTD
-24.45 8.42% 1Y
+16.15 6.46% 3Y
-26.74 9.14% 5Y
+211.54 388.65% 10Y
+251.78 1,774.35% 20Y
NYSE, Closing price Tue, Oct 07 2025
-2.10 0.78%

Key metrics

Basic
Market capitalization
$19.1b
Enterprise Value
$18.8b
Net debt
positive
Cash
$509.7m
Shares outstanding
71.9m
Valuation (TTM | estimate)
P/E
39.6 | 38.9
P/S
6.5 | 6.2
EV/Sales
6.4 | 6.1
EV/FCF
54.7
P/B
6.5
Dividends
DPS
$0.82
Yield 1Y | 5Y
0.3% | 0.2%
Growth 1Y | 5Y
5.1% | 5.8%
Payout 1Y | 3Y
12.3% | 10.5%
Increased
25 Years
Financials (TTM | estimate)
Revenue
$3.0b | $3.1b
EBITDA
$778.2m | $749.9m
EBIT
$615.9m | $581.0m
Net Income
$487.7m | $491.2m
Free Cash Flow
$344.0m
Growth (TTM | estimate)
Revenue
2.9% | 6.3%
EBITDA
3.7% | 0.7%
EBIT
2.0% | -1.4%
Net Income
-7.1% | -0.3%
Free Cash Flow
-3.7%
Margin (TTM | estimate)
Gross
35.3%
EBITDA
26.3% | 24.4%
EBIT
20.8%
Net
16.5% | 16.0%
Free Cash Flow
11.6%
Financial Health
Equity Ratio
73.6%
Return on Equity
18.4%
ROCE
18.4%
ROIC
16.5%
Debt/Equity
0.1
More
EPS
$6.7
FCF per Share
$4.8
Short interest
3.1%
Employees
11k
Rev per Employee
$270.0k
Show more

Is West Pharmaceutical Services, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

West Pharmaceutical Services, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

15x Buy
75%
5x Hold
25%

Analyst Opinions

20 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

Buy
75%
Hold
25%

Financial data from West Pharmaceutical Services, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,960 2,960
3% 3%
100%
- Direct Costs 1,916 1,916
4% 4%
65%
1,044 1,044
2% 2%
35%
- Selling and Administrative Expenses 350 350
0% 0%
12%
- Research and Development Expense 69 69
1% 1%
2%
778 778
4% 4%
26%
- Depreciation and Amortization 162 162
11% 11%
5%
EBIT (Operating Income) EBIT 616 616
2% 2%
21%
Net Profit 488 488
7% 7%
16%

In millions USD.

Don't miss a Thing! We will send you all news about West Pharmaceutical Services, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

West Pharmaceutical Services, Inc. Stock News

Positive
Seeking Alpha
6 days ago
The Top 15 High-Growth Dividend Stock list for October 2025 targets a 12% long-term return, despite underperforming SPY and VIG in September. These 15 stocks offer a 1.4% average yield and have grown dividends at 19.1% annually over five years, with many trading at significant discounts. Recent changes include six new additions, with expected long-term CAGRs near 20% based on dividend yield the...
Neutral
Seeking Alpha
14 days ago
West Pharmaceutical Services, Inc. (NYSE:WST ) Bank of America Global Healthcare Conference 2025 September 24, 2025 10:05 AM EDT Company Participants Eric Green - Non-Independent Chair of the Board, President & CEO Robert McMahon - Senior VP & CFO Conference Call Participants Michael Ryskin - BofA Securities, Research Division Presentation Michael Ryskin BofA Securities, Research Division Thank...
Positive
Seeking Alpha
about one month ago
I track a universe of 50 high-quality dividend growth stocks to identify attractive investment opportunities based on valuation and future return potential. My custom valuation model highlights 23 stocks with estimated future returns above 10%, with 12 of these also appearing undervalued by free cash flow. Top picks include Resmed, MarketAxess, Ferrari, MSCI, Accenture, and others, each offerin...
More West Pharmaceutical Services, Inc. News

Company Profile

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Head office United States
CEO Eric Green
Employees 10,600
Founded 1923
Website www.westpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today